Sign Up to like & get
recommendations!
0
Published in 2018 at "Cancer Research"
DOI: 10.1158/1538-7445.am2018-4108
Abstract: Background and Purpose: Oncogenic NRAS, which drives the constitutive activation of the RAS-RAF-MEK-ERK pathway, is expressed in 15–20% of melanomas and is the second most common driver mutation in this disease. Inhibition of oncogenic RAS…
read more here.
Keywords:
nras mutant;
diffusion;
diffusion weighted;
dual raf ... See more keywords